RE:RE:RE:RE:RE:Next StepsLABS has an edge intly. It has experience navigating different jurisdictions and has a good network foundation.
It's intl oil and derivatives GMP licences are rare in the industry, considering most intl GMP licences in the industry are for flower. Additionnaly, those licences take resources and time to obtain.
Also, as mentioned, it now has strong track record for production, reputation for quality, and relationships with a variety of businesses amongst which STADA.
US based medical cannabis companies can't just make all of this appear (licences and network) the day mj is legalized, and that is when it is legalized. Even if Biden is elected and goes forth with legalization, it likely isn't happening before 2022.